Haematology part 2 (p22-34- leukaemia, lymphomas, myeloproliferative + transfusions) Flashcards
(83 cards)
Clinical features of acute leukaemia?
BM function failure- anaemia, thrombocytopenia (bleeding) + neuropenia (infection)
Organ infiltration- hepatomegaly, splenomegaly, lymphadenopathy, bone pain, CNS, skin, gum hypertrophy
What causes acute leukaemia?
Most of the time unknown Ionising radiation- radiotherapy Cytotoxic drugs- chemo Benzene Pre-leukaemic disorders- MDS, MPD Down's Neonates
How is haematological malignancy diagnosed?
Morphology +/- cytochemistry (stains) Immunophenotyping using flow cytometry (lineage, differentiation) Cytogenetics (chromsomal translocations) Molecular genetics (PCR, point mutations etc)
Epidemiology of ALL?
Children (ALL children get cancer)
Epidemiology of AML?
Adulthood (risk increases with age) and under 2s (infant peak)
Clinical features of ALL?
Anaemia Thromobocytopenia Neutropenia Lymphadenopathy+++ CNS involvement+++ Testicular enlargement Thymic enlargement
Clinical features of AML?
Anaemia
Thrombocytopenia
Neutropenia
Investigation findings for ALL?
High WCC (blasts) Lymphocytes+++
Flow cytometry:
CD34- Precursor/stem cells
CD3- T lymphocytes
CD19- B lymphocytes
Investigation findings for AML?
High WCC (blasts) Auer rods and granules
Flow cytometry:
CD34: precursor/stem cells
MPO: myeloid cells
What is the treatment for ALL?
Chemotherapy:
Remission induction- chemo agents with steroids
Consolidation- high dose multi drug chemo
CNS treatment
Maintenance- 2y in girls and adults, 3y in boys
Supportive:
Blood products, abx, allopurinol, fluid, electrolytes
What is the treatment for AML?
Chemo:
Similar to ALL but no CNS prophylaxis/maintenance therapy
(ATRA for M3 subtype)
Supportive:
Blood products, abx, allopurinol, fluid, electrolytes
Epidemiology of CML?
Middle aged typically 40-60
Investigation findings for CML?
Ph +ve (philadelphia chromosome) in 80%
PCR for BCR-ABL (philadelphia ch) fusion gene
WBC, Neutrophils 50-5000
Hypercellular BM with spectrum of immature and mature granulocytic cells in the blood
On examination- massive splenomegaly
Three different phases of CML?
Chronic phase
Accelerated phase
Blast phase
How is chronic phase CML treated?
Imatinib (BCR-ABL tyrosine kinase inhibitor)
Highly effective
Epidemiology of CLL?
M>F, elderly
Clinical features of CLL?
Asymptomatic and diagnosed on bloods in 80% of cases
Symmetrical painless lymphadenopathy
BM failure- anaemia, thrombocytopenia, neutropenia
Weight loss, fever, night sweats
Hepatomegaly and splenomegaly
Investigation findings for CLL?
High WBC with lymphocytosis >5
Low serum Ig
Smear cells (SMEAR CLLs)- blood film
What is the staging for CLL?
Binet:
Stage A- High WBC, <3 groups of enlarged lymph nodes and no treatment required
Stage B- >3 groups of enlarged lymph nodes
Stage C- Anaemia or thrombocytopenia
Treatment for CLL?
Many benefit from watchful waiting
Supportive treatment with transfusions, infection prophylaxis
1st line- if p53 deletion = alemtuzumab otherwise chlorambucil
What is a lymphoma?
Neoplastic tumour of lymphoid tissue (lymph nodes, spleen, MALT etc)
Epidemiology of Hodgkin’s lymphoma?
20% of lymphoma
M>F
Bimodal age incidence- 20-29 and >60
EBV associated
Clinical presentation of Hodgkin’s lymphoma?
Asymmetrical painless lymphadenopathy +/- obstructive/mass effect symptoms
B-symptoms (fever >38, drenching night sweats + weight loss >10% in 6m)
Pain in affected nodes after ALCOHOL
Investigations + findings for Hodgkin’s lymphoma?
CT/PET
Tissue diagnosis- LN or BM biopsy- cells stain with CD15+CD30
REED-STERNBERG cells- binucleate (owl eyed) cell